Can longstanding prediabetes progress to overt hyperglycemia?

Prediabetes is a heterogeneous risk state rather than a fixed pathway, but its progression to overt hyperglycemia/type 2 diabetes is well established. For a 77-year-old, age and competing health risks importantly affect the absolute likelihood and clinical priorities.

Clinical evidence

• A meta-analysis of 70 prospective studies found annual diabetes incidence of approximately 3.6% with ADA-defined impaired fasting glucose plus HbA1c 6.0–6.4%, 4.6%–4.7% with impaired glucose tolerance or WHO-defined impaired fasting glucose, and 7.0% when impaired fasting glucose and impaired glucose tolerance coexisted.
• In the ARIC cohort (mean age 75.6 years; about six years’ follow-up), 8% of people with impaired fasting glucose and 9% with HbA1c-defined prediabetes developed diabetes. Regression to normoglycemia, and death, were more frequent than progression.
• Higher baseline fasting glucose and HbA1c predict incident diabetes, with risk rising nonlinearly at higher values.

Mechanisms

• Progressors show worsening insulin resistance: in one five-year cohort, resistance rose 31% in those developing diabetes versus a 29% decline in people regressing to normal glucose regulation. Clamp-measured insulin sensitivity fell 10% over 5.5 years in those developing prediabetes, versus 2.5% in nonprogressors.
• The critical accompanying defect is inadequate beta-cell adaptation. In progression from impaired glucose tolerance to diabetes, insulin secretion declined 78%, compared with a 14% decline in insulin sensitivity; nonprogressors maintained compensatory secretion. A lower oral disposition index predicted diabetes in 517 Asian Indian men with impaired glucose tolerance (AUC 0.717; 95% CI 0.675–0.756).

Clinical implications

• At least annual glycemic monitoring is appropriate; worsening HbA1c or fasting glucose, especially HbA1c ≥6.0% or fasting glucose 110–125 mg/dL, identifies higher-risk trajectories.

Bottom line

• Prediabetes can progress as insulin resistance increases and beta-cell reserve fails, but progression is not inevitable—particularly in older adults, among whom regression is common.